These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10736292)

  • 1. Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost.
    Alt E; Haehnel I; Beilharz C; Prietzel K; Preter D; Stemberger A; Fliedner T; Erhardt W; Schömig A
    Circulation; 2000 Mar; 101(12):1453-8. PubMed ID: 10736292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic stent coatings: hirudin/iloprost combination.
    Alt E; Seliger C
    Semin Interv Cardiol; 1998; 3(3-4):177-83. PubMed ID: 10406690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombogenic coating of stents using a biodegradable drug delivery technology.
    Herrmann R; Schmidmaier G; Märkl B; Resch A; Hähnel I; Stemberger A; Alt E
    Thromb Haemost; 1999 Jul; 82(1):51-7. PubMed ID: 10456454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model.
    Lincoff AM; Furst JG; Ellis SG; Tuch RJ; Topol EJ
    J Am Coll Cardiol; 1997 Mar; 29(4):808-16. PubMed ID: 9091528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple-coated stents (Hirudin/Iloprost/Paclitaxel): an in vitro approach for characterizing the antiproliferative potential of each individual compound.
    Voisard R; Stemberger A; Baur R; Herter T; Hähnel I; Resch A; Seliger C; Hemmer W; Hannekum A; Hombach V; Alt E
    Int J Cardiol; 2005 Jul; 102(3):425-33. PubMed ID: 16004887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.
    Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A
    Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained-release local hirulog therapy decreases early thrombosis but not neointimal thickening after arterial stenting.
    Muller DW; Gordon D; Topol EJ; Levy RJ; Golomb G
    Am Heart J; 1996 Feb; 131(2):211-8. PubMed ID: 8579010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo.
    Yamawaki T; Shimokawa H; Kozai T; Miyata K; Higo T; Tanaka E; Egashira K; Shiraishi T; Tamai H; Igaki K; Takeshita A
    J Am Coll Cardiol; 1998 Sep; 32(3):780-6. PubMed ID: 9741527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.
    Heldman AW; Cheng L; Jenkins GM; Heller PF; Kim DW; Ware M; Nater C; Hruban RH; Rezai B; Abella BS; Bunge KE; Kinsella JL; Sollott SJ; Lakatta EG; Brinker JA; Hunter WL; Froehlich JP
    Circulation; 2001 May; 103(18):2289-95. PubMed ID: 11342479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial Effects of a Novel Bioabsorbable Polymer Coating on Enhanced Coronary Vasoconstricting Responses After Drug-Eluting Stent Implantation in Pigs in Vivo.
    Nishimiya K; Matsumoto Y; Uzuka H; Ogata T; Hirano M; Shindo T; Hasebe Y; Tsuburaya R; Shiroto T; Takahashi J; Ito K; Shimokawa H
    JACC Cardiovasc Interv; 2016 Feb; 9(3):281-291. PubMed ID: 26847120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
    Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
    Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local delivery of platelets with encapsulated iloprost to balloon injured pig carotid arteries: effect on platelet deposition and neointima formation.
    Banning A; Brewer L; Wendt M; Groves PH; Cheadle H; Penny WJ; Crawford N
    Thromb Haemost; 1997 Jan; 77(1):190-6. PubMed ID: 9031472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries.
    Speck U; Scheller B; Abramjuk C; Breitwieser C; Dobberstein J; Boehm M; Hamm B
    Radiology; 2006 Aug; 240(2):411-8. PubMed ID: 16864669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEG-hirudin/iloprost coating of small diameter ePTFE grafts effectively prevents pseudointima and intimal hyperplasia development.
    Heise M; Schmidmaier G; Husmann I; Heidenhain C; Schmidt J; Neuhaus P; Settmacher U
    Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):418-24. PubMed ID: 16682237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer stent coating for prevention of neointimal hyperplasia.
    Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
    J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent and biodegradable polymer coatings in the absence of antiproliferative drugs in a porcine model of coronary artery stenting.
    Koppara T; Wittchow E; Byrne RA; Bayer G; Diener T; Joner M
    EuroIntervention; 2016 Jan; 11(9):1020-6. PubMed ID: 25317851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary stenting with a novel stainless steel balloon-expandable stent: determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model.
    Carter AJ; Laird JR; Kufs WM; Bailey L; Hoopes TG; Reeves T; Farb A; Virmani R
    J Am Coll Cardiol; 1996 Apr; 27(5):1270-7. PubMed ID: 8609355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary stent symmetry and vascular injury determine experimental restenosis.
    Schulz C; Herrmann RA; Beilharz C; Pasquantonio J; Alt E
    Heart; 2000 Apr; 83(4):462-7. PubMed ID: 10722552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.